These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30032193)

  • 1. Aromatized Estrogens Amplify Nocturnal Growth Hormone Secretion in Testosterone-Replaced Older Hypogonadal Men.
    Roelfsema F; Yang RJ; Takahashi PY; Erickson D; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2018 Dec; 103(12):4419-4427. PubMed ID: 30032193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone-releasing hormone.
    Bondanelli M; Ambrosio MR; Margutti A; Franceschetti P; Zatelli MC; degli Uberti EC
    Neuroendocrinology; 2003 Jun; 77(6):380-7. PubMed ID: 12845224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotrophic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth hormone-releasing hormone pulsatile infusion in men.
    Iranmanesh A; South S; Liem AY; Clemmons D; Thorner MO; Weltman A; Veldhuis JD
    Eur J Endocrinol; 1998 Jul; 139(1):59-71. PubMed ID: 9703380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preservation of GHRH and GH-releasing peptide-2 efficacy in young men with experimentally induced hypogonadism.
    Veldhuis JD; Keenan DM; Bailey JN; Miles JM; Bowers CY
    Eur J Endocrinol; 2009 Aug; 161(2):293-300. PubMed ID: 19458139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states.
    Evans WS; Anderson SM; Hull LT; Azimi PP; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Feb; 86(2):700-12. PubMed ID: 11158034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of estradiol supplementation on dual peptidyl drive of GH secretion in postmenopausal women.
    Veldhuis JD; Evans WS; Bowers CY
    J Clin Endocrinol Metab; 2002 Feb; 87(2):859-66. PubMed ID: 11836333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre- versus postmenopausal age, estradiol, and peptide-secretagogue type determine pulsatile growth hormone secretion in healthy women: studies using submaximal agonist drive and an estrogen clamp.
    Hudson SB; Schroeder DR; Bailey JN; Mielke KL; Erickson D; Miles JM; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2010 Jan; 95(1):353-60. PubMed ID: 19858315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretagogues govern GH secretory-burst waveform and mass in healthy eugonadal and short-term hypogonadal men.
    Veldhuis JD; Keenan DM
    Eur J Endocrinol; 2008 Nov; 159(5):547-54. PubMed ID: 18703567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral estradiol administration modulates continuous intravenous growth hormone (GH)-releasing peptide-2-driven GH secretion in postmenopausal women.
    Shah N; Evans WS; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2649-59. PubMed ID: 10946861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maturation of the regulation of growth hormone secretion in young males with hypogonadotropic hypogonadism pharmacologically exposed to progressive increments in serum testosterone.
    Giustina A; Scalvini T; Tassi C; Desenzani P; Poiesi C; Wehrenberg WB; Rogol AD; Veldhuis JD
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1210-9. PubMed ID: 9100598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aromatase and 5alpha-reductase inhibition during an exogenous testosterone clamp unveils selective sex steroid modulation of somatostatin and growth hormone secretagogue actions in healthy older men.
    Veldhuis JD; Mielke KL; Cosma M; Soares-Welch C; Paulo R; Miles JM; Bowers CY
    J Clin Endocrinol Metab; 2009 Mar; 94(3):973-81. PubMed ID: 19088159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tripartite neuroendocrine activation of the human growth hormone (GH) axis in women by continuous 24-hour GH-releasing peptide infusion: pulsatile, entropic, and nyctohemeral mechanisms.
    Shah N; Evans WS; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2140-50. PubMed ID: 10372723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous Estrogen Regulates Somatostatin-Induced Rebound GH Secretion in Postmenopausal Women.
    Veldhuis JD; Erickson D; Yang R; Takahashi P; Bowers C
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4298-4304. PubMed ID: 27459535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estradiol regulates GH-releasing peptide's interactions with GH-releasing hormone and somatostatin in postmenopausal women.
    Norman C; Rollene NL; Erickson D; Miles JM; Bowers CY; Veldhuis JD
    Eur J Endocrinol; 2014 Jan; 170(1):121-9. PubMed ID: 24114435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender, sex-steroid, and secretagogue-selective recovery from growth hormone-induced feedback in older women and men.
    Veldhuis JD; Erickson D; Wigham J; Weist S; Miles JM; Bowers CY
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2540-7. PubMed ID: 21613353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of transdermal testosterone gel or an aromatase inhibitor on serum concentration and pulsatility of growth hormone in older men with age-related low testosterone.
    Dias JP; Veldhuis JD; Carlson O; Shardell M; Chia CW; Melvin D; Egan JM; Basaria S
    Metabolism; 2017 Apr; 69():143-147. PubMed ID: 28285644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel relationships of age, visceral adiposity, insulin-like growth factor (IGF)-I and IGF binding protein concentrations to growth hormone (GH) releasing-hormone and GH releasing-peptide efficacies in men during experimental hypogonadal clamp.
    Veldhuis JD; Keenan DM; Bailey JN; Adeniji AM; Miles JM; Bowers CY
    J Clin Endocrinol Metab; 2009 Jun; 94(6):2137-43. PubMed ID: 19351723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex steroids, GHRH, somatostatin, IGF-I, and IGFBP-1 modulate ghrelin's dose-dependent drive of pulsatile GH secretion in healthy older men.
    Veldhuis JD; Norman C; Miles JM; Bowers CY
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4753-60. PubMed ID: 22990092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone supplementation in healthy older men drives GH and IGF-I secretion without potentiating peptidyl secretagogue efficacy.
    Veldhuis JD; Keenan DM; Mielke K; Miles JM; Bowers CY
    Eur J Endocrinol; 2005 Oct; 153(4):577-86. PubMed ID: 16189179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estradiol supplementation in postmenopausal women doubles rebound-like release of growth hormone (GH) triggered by sequential infusion and withdrawal of somatostatin: evidence that estrogen facilitates endogenous GH-releasing hormone drive.
    Veldhuis JD; Anderson SM; Patrie JT; Bowers CY
    J Clin Endocrinol Metab; 2004 Jan; 89(1):121-7. PubMed ID: 14715838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.